Literature DB >> 15762814

The effects of benzodiazepines on cognition.

Samantha A Stewart1.   

Abstract

Initially thought to be virtually free of negative effects, benzodiazepines are now known to carry risks of dependence, withdrawal, and negative side effects. Among the most controversial of these side effects are cognitive effects. Long-term treatment with benzodiazepines has been described as causing impairment in several cognitive domains, such as visuospatial ability, speed of processing, and verbal learning. Conversely, long-term benzodiazepine use has also been described as causing no chronic cognitive impairment, with any cognitive dysfunction in patients ascribed to sedation or inattention or considered temporary and associated with peak plasma levels. Complicating the issue are whether anxiety disorders themselves are associated with cognitive deficits and the extent to which patients are aware of their own cognitive problems. In an attempt to settle this debate, meta-analyses of peer-reviewed studies were conducted and found that cognitive dysfunction did in fact occur in patients treated long term with benzodiazepines, and although cognitive dysfunction improved after benzodiazepines were withdrawn, patients did not return to levels of functioning that matched benzodiazepine-free controls. Neuroimaging studies have found transient changes in the brain after benzodiazepine administration but no brain abnormalities in patients treated long term with benzodiazepines. Such findings suggest that patients should be advised of potential cognitive effects when treated long term with benzodiazepines, although they should also be informed that the impact of such effects may be insignificant in the daily functioning of most patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15762814

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  74 in total

Review 1.  GABA(A) receptor physiology and its relationship to the mechanism of action of the 1,5-benzodiazepine clobazam.

Authors:  Raman Sankar
Journal:  CNS Drugs       Date:  2012-03-01       Impact factor: 5.749

2.  Relations Between Cognitive Functioning and Alcohol Use, Craving, and Post-Traumatic Stress: An Examination Among Trauma-Exposed Military Veterans With Alcohol Use Disorder.

Authors:  Adrienne J Heinz; David L Pennington; Nicole Cohen; Brandi Schmeling; Brooke A Lasher; Emily Schrodek; Steven L Batki
Journal:  Mil Med       Date:  2016-07       Impact factor: 1.437

3.  Trends in Insomnia Diagnosis and Treatment Among Medicare Beneficiaries, 2006-2013.

Authors:  Jennifer S Albrecht; Emerson M Wickwire; Aparna Vadlamani; Steven M Scharf; Sarah E Tom
Journal:  Am J Geriatr Psychiatry       Date:  2018-11-02       Impact factor: 4.105

Review 4.  Neuropsychiatric effects of prescription drug abuse.

Authors:  Jason P Caplan; Lucy A Epstein; Davin K Quinn; Jonathan R Stevens; Theodore A Stern
Journal:  Neuropsychol Rev       Date:  2007-08-16       Impact factor: 7.444

5.  Effect of adjunctive benzodiazepines on clinical outcomes in lithium- or quetiapine-treated outpatients with bipolar I or II disorder: results from the Bipolar CHOICE trial.

Authors:  William V Bobo; Noreen A Reilly-Harrington; Terence A Ketter; Benjamin D Brody; Gustavo Kinrys; David E Kemp; Richard C Shelton; Susan L McElroy; Louisa G Sylvia; James H Kocsis; Melvin G McInnis; Edward S Friedman; Vivek Singh; Mauricio Tohen; Charles L Bowden; Thilo Deckersbach; Joseph R Calabrese; Michael E Thase; Andrew A Nierenberg; Dustin J Rabideau; David A Schoenfeld; Stephen V Faraone; Masoud Kamali
Journal:  J Affect Disord       Date:  2014-03-13       Impact factor: 4.839

6.  Impact of medications on cognitive function in obstructive sleep apnea syndrome.

Authors:  Chitra Lal; Nasar Siddiqi; Suchit Kumbhare; Charlie Strange
Journal:  Sleep Breath       Date:  2015-01-08       Impact factor: 2.816

7.  Use of potentially inappropriate medications among ambulatory home-dwelling elderly patients with dementia: A review of the literature.

Authors:  Tejal Patel; Karen Slonim; Linda Lee
Journal:  Can Pharm J (Ott)       Date:  2017-05-01

8.  Multifocal cognitive dysfunction in high-dose benzodiazepine users: a cross-sectional study.

Authors:  Angela Federico; Stefano Tamburin; Alice Maier; Marco Faccini; Rebecca Casari; Laura Morbioli; Fabio Lugoboni
Journal:  Neurol Sci       Date:  2016-10-11       Impact factor: 3.307

Review 9.  Antiepileptic drug-induced cognitive adverse effects: potential mechanisms and contributing factors.

Authors:  Marco Mula; Michael R Trimble
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

10.  Effects of etizolam and ethyl loflazepate on the P300 event-related potential in healthy subjects.

Authors:  Goro Fukami; Tasuku Hashimoto; Yukihiko Shirayama; Tadashi Hasegawa; Hiroyuki Watanabe; Mihisa Fujisaki; Kenji Hashimoto; Masaomi Iyo
Journal:  Ann Gen Psychiatry       Date:  2010-11-03       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.